Squarepoint
RXST icon

Squarepoint’s RxSight RXST Stock Holding History

Squarepoint’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$90.5K Sell
18,768
-12,550
-40% -$75.8K ﹤0.01% 4217
2026
Q1 		$193K Buy
31,318
+1,007
+3% +$8.36K ﹤0.01% 3968
2025
Q4 		$316K Sell
30,311
-60,272
-67% -$605K ﹤0.01% 3564
2025
Q3 		$814K Sell
90,583
-284,080
-76% -$2.49M ﹤0.01% 2858
2025
Q2 		$4.87M Buy
374,663
+217,608
+139% +$3.27M 0.01% 1489
2025
Q1 		$3.97M Buy
157,055
+23,930
+18% +$711K ﹤0.01% 1586
2024
Q4 		$4.58M Buy
133,125
+14,799
+13% +$667K ﹤0.01% 1714
2024
Q3 		$5.85M Buy
118,326
+20,286
+21% +$1.04M 0.01% 1307
2024
Q2 		$5.9M Sell
98,040
-11,447
-10% -$654K 0.01% 1263
2024
Q1 		$5.65M Buy
109,487
+27,504
+34% +$1.35M 0.01% 1360
2023
Q4 		$3.31M Buy
81,983
+59,123
+259% +$1.73M 0.01% 1656
2023
Q3 		$638K Buy
+22,860
New +$682K ﹤0.01% 2612

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Squarepoint's RXST Position: Q2 2026 in Review

Squarepoint reduced its RxSight (RXST) stake by 40% in Q2 2026, selling an estimated $75.8K and leaving 18,768 shares worth $90.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4217.

Squarepoint first reported a position in RXST in Q3 2023 and has held it in 12 quarters since. The position peaked at $5.9M in Q2 2024. 152 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Squarepoint held 18,768 shares of RxSight worth $90.5K as of Q2 2026.
  • Squarepoint sold 12,550 RxSight shares in Q2 2026, an estimated $75.8K.
  • RxSight made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #4217 holding.
  • Squarepoint first reported a position in RxSight in Q3 2023 and has held it in 12 quarters since.
  • Squarepoint's RxSight position peaked at $5.9M in Q2 2024.
  • 152 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.